Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons

Surg Oncol Clin N Am. 2024 Apr;33(2):447-466. doi: 10.1016/j.soc.2023.12.009. Epub 2024 Jan 27.ABSTRACTAlthough there are more than 100 clinically distinct lymphoid neoplasms with varied prognoses and treatment approaches, they generally share high sensitivity to glucocorticoids, cytotoxic chemotherapy, and radiation. The disease control rates for lymphoid malignancies are higher than many solid tumors, and many are curable even when presenting with extensive involvement. Novel targeted therapies have improved disease control and cure rates for nearly all subtypes of lymphoid neoplasms. Surgical oncologists will primarily be involved in obtaining biopsies of sufficient quality to allow accurate diagnosis. However, there are scenarios in which surgical intervention may be necessary to address an oncologic emergency.PMID:38401918 | DOI:10.1016/j.soc.2023.12.009
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research